IE
FMI

Israel Englander’s Foundation Medicine, Inc. FMI Stock Holding History

Israel Englander’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-77,500
Closed -$2.09M – 4179
2014
Q2 		$2.09M Buy
+77,500
New +$1.96M 0.01% 1742

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Israel Englander's FMI Position: Q1 2018 in Review

Israel Englander sold out of Foundation Medicine, Inc. (FMI) in Q1 2018, closing a stake of 26,056 shares — an estimated $1.78M sold.

Israel Englander first reported a position in FMI in Q4 2013 and held it in 13 quarters. The position peaked at $6.77M in Q3 2015. 144 funds tracked by Wall St. Rank hold FMI as of Q1 2018.

  • Israel Englander reported no remaining Foundation Medicine, Inc. position as of Q1 2018 after selling out during the quarter.
  • Israel Englander sold 26,056 Foundation Medicine, Inc. shares in Q1 2018, an estimated $1.78M.
  • Israel Englander first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 13 quarters.
  • Israel Englander's Foundation Medicine, Inc. position peaked at $6.77M in Q3 2015.
  • 144 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.